ArticleStroke (Hoboken, N.J.)2026
One-Stop Management Improves Outcome for Large Vessel Occlusion Stroke.
Article in Stroke (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03356392 (German Stroke Registry - Endovascular Treatment), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
German Stroke Registry - Endovascular Treatment
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTime to mechanical thrombectomy (MT) is a critical predictor of functional outcomes in large vessel occlusion stroke. This study compares 2 large vessel occlusion stroke treatment approaches: the one-stop management approach (OSM), in which patients are directly transferred to the angiosuite for flat detector computed tomography and MT, versus the conventional approach, which includes multidetector CT before MT.
methodsBetween March 2014 and December 2019, 205 patients with acute ischemic stroke with a National Institutes of Health Stroke Scale (NIHSS) score of ≥7 and symptom onset ≤4.5 hours underwent large vessel occlusion stroke-treatment using the OSM approach at the University Medical Center Göttingen, Germany. After confirmation of LVO, eligible patients received intravenous thrombolysis followed by MT. Ordinal regression corrected for all confounders. Primary end points included door-to-groin and door-to-reperfusion times, NIHSS at discharge, NIHSS improvement, and modified Rankin Scale at 90 days. Propensity score matching accounted for age, sex, NIHSS, thrombolysis, Thrombolysis in Cerebral Ischemia score, and post-MT intracranial hemorrhage. Treatment times were noncensored.
resultsCompared with 2470 patients from the German Stroke Registry treated conventionally (non-OSM group), OSM patients had significantly shorter door-to-groin (33.33±±17.91 versus 95.73±±158.33 minutes;
conclusionsIn this observational trial, direct angiosuite transfer for large vessel occlusion stroke treatment reduces periprocedural times and is associated with improved functional outcomes compared with a conventional approach using multidetector CT before MT. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03356392.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.